Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ENCOMPASS.NET

K-Number: K053455 · 2006-01-25

Decision Date2006-01-25
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

ENCOMPASS.NET is the device name listed in this FDA 510(k) record. The listed applicant is Empiric Systems, LLC. It received FDA 510(k) clearance on 2006-01-25 under 510(k) number K053455. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ENCOMPASS.NET?

ENCOMPASS.NET is a medical device that received FDA 510(k) clearance on 2006-01-25. The listed applicant is Empiric Systems, LLC. The 510(k) number is K053455.

When did ENCOMPASS.NET receive FDA 510(k) clearance?

ENCOMPASS.NET received FDA 510(k) clearance on 2006-01-25, under 510(k) number K053455.

Who is the listed applicant for ENCOMPASS.NET?

The FDA 510(k) record lists Empiric Systems, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ENCOMPASS.NET?

The FDA product code for ENCOMPASS.NET is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑